Literature DB >> 30264730

The hippocampus in multiple sclerosis.

Maria A Rocca1, Frederik Barkhof2, John De Luca3, Jonas Frisén4, Jeroen J G Geurts5, Hanneke E Hulst5, Jaume Sastre-Garriga6, Massimo Filippi7.   

Abstract

Some of the clinical manifestations of multiple sclerosis, such as memory impairment and depression, are, at least partly, related to involvement of the hippocampus. Pathological studies have shown extensive demyelination, neuronal damage, and synaptic abnormalities in the hippocampus of patients with multiple sclerosis, and improvements in MRI technology have provided novel ways to assess hippocampal involvement in vivo. It is now accepted that clinical manifestations related to the hippocampus are due not only to focal hippocampal damage, but also to disconnection of the hippocampus from several brain networks. Evidence suggests anatomical and functional subspecialisation of the different hippocampal subfields, resulting in variability between regions in the extent to which damage and repair occur. The hippocampus also has important roles in plasticity and neurogenesis, both of which potentially contribute to functional preservation and restoration. These findings underline the importance of evaluation of the hippocampus not only to improve understanding of the clinical manifestations of multiple sclerosis, but also as a potential future target for treatment.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30264730     DOI: 10.1016/S1474-4422(18)30309-0

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  26 in total

1.  Depression Comorbid With Stroke, Traumatic Brain Injury, Parkinson's Disease, and Multiple Sclerosis: Diagnosis and Treatment.

Authors:  Susan K Conroy; Katherine B Brownlowe; Thomas W McAllister
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

Review 2.  Beyond the neuron: Role of non-neuronal cells in stress disorders.

Authors:  Flurin Cathomas; Leanne M Holt; Eric M Parise; Jia Liu; James W Murrough; Patrizia Casaccia; Eric J Nestler; Scott J Russo
Journal:  Neuron       Date:  2022-02-18       Impact factor: 17.173

3.  Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients.

Authors:  Ermelinda De Meo; Emilio Portaccio; Elio Prestipino; Benedetta Nacmias; Silvia Bagnoli; Lorenzo Razzolini; Luisa Pastò; Claudia Niccolai; Benedetta Goretti; Angelo Bellinvia; Mattia Fonderico; Antonio Giorgio; Maria Laura Stromillo; Massimo Filippi; Sandro Sorbi; Nicola De Stefano; Maria Pia Amato
Journal:  Mol Psychiatry       Date:  2021-10-14       Impact factor: 15.992

4.  Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls.

Authors:  Dejan Jakimovski; Niels Bergsland; Michael G Dwyer; Jesper Hagemeier; Deepa P Ramasamy; Kinga Szigeti; Thomas Guttuso; David Lichter; David Hojnacki; Bianca Weinstock-Guttman; Ralph H B Benedict; Robert Zivadinov
Journal:  Neurobiol Aging       Date:  2020-02-08       Impact factor: 4.673

5.  Sleep disturbance and memory dysfunction in early multiple sclerosis.

Authors:  James F Sumowski; Sam Horng; Rachel Brandstadter; Stephen Krieger; Victoria M Leavitt; Ilana Katz Sand; Michelle Fabian; Sylvia Klineova; Robin Graney; Claire S Riley; Fred D Lublin; Aaron E Miller; Andrew W Varga
Journal:  Ann Clin Transl Neurol       Date:  2021-05-05       Impact factor: 4.511

6.  Hippocampal volume is more related to patient-reported memory than objective memory performance in early multiple sclerosis.

Authors:  Lisa Glukhovsky; Rachel Brandstadter; Victoria M Leavitt; Stephen Krieger; Korhan Buyukturkoglu; Michelle Fabian; Ilana Katz Sand; Sylvia Klineova; Claire S Riley; Fred D Lublin; Aaron E Miller; James F Sumowski
Journal:  Mult Scler       Date:  2020-06-22       Impact factor: 5.855

7.  Platelet Depletion is Effective in Ameliorating Anxiety-Like Behavior and Reducing the Pro-Inflammatory Environment in the Hippocampus in Murine Experimental Autoimmune Encephalomyelitis.

Authors:  Pece Kocovski; Xiangrui Jiang; Claretta S D'Souza; Zhenjiang Li; Phuc T Dang; Xiaowei Wang; Weisan Chen; Karlheinz Peter; Matthew W Hale; Jacqueline M Orian
Journal:  J Clin Med       Date:  2019-02-01       Impact factor: 4.241

Review 8.  Treatment and management of cognitive dysfunction in patients with multiple sclerosis.

Authors:  John DeLuca; Nancy D Chiaravalloti; Brian M Sandroff
Journal:  Nat Rev Neurol       Date:  2020-05-05       Impact factor: 42.937

9.  Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior.

Authors:  Pece Kocovski; Nuzhat Tabassum-Sheikh; Stephanie Marinis; Phuc T Dang; Matthew W Hale; Jacqueline M Orian
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

10.  Proteomic differences in the hippocampus and cortex of epilepsy brain tissue.

Authors:  Geoffrey Pires; Dominique Leitner; Eleanor Drummond; Evgeny Kanshin; Shruti Nayak; Manor Askenazi; Arline Faustin; Daniel Friedman; Ludovic Debure; Beatrix Ueberheide; Thomas Wisniewski; Orrin Devinsky
Journal:  Brain Commun       Date:  2021-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.